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Abstract
BACKGROUND: Glutamine is a non-essential amino acid as the main fuel in the gastrointestinal mucosa. By its 
various gastrointestinal functions, glutamine is thought to increase the protection of the intestinal mucosa against 
local or systemic injury from diarrhea.
AIM: This study aimed to determine the relationship between glutamine supplementation and fecal calprotectin and 
tumor necrosis factor-α (TNF-α) in the fecal of rats with acute and chronic diarrhea induced by EPEC.
MATERIALS AND METHODS: The research was conducted in an experimental laboratory with a randomized post-
test only control group design. A total of 30 Rattus norvegicus strain Wistar were divided into five groups. The 
treatment group was induced to have diarrhea using EPEC at a dose of 108 CFU/ml, after each group diagnosed 
by acute and chronic diarrhea, followed by glutamine supplementation at a dose of 810 mg/200 g for 14 days. The 
inflammatory cytoknies which is fecal calprotectin and TNF-α, of each group was assessed and the p value was 
measured by one-way ANOVA and post hoc Bonferroni test to find out the relationship between these variables.
RESULT: Supplementation of glutamine for 14 days can reduce fecal calprotectin levels in chronic diarrhea and 
reduce TNF-α level in rats with acute and chronic diarrhea.
CONCLUSION: Glutamine supplementation has an effect on the fecal calprotectin and TNF-α of rats with acute and 
chronic diarrhea.
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Introduction
Diarrhea is a condition in which tools are 
passed with a watery consistency that usually occurs 
with a frequency of more than 3 times/day [1]. Diarrhea 
is a major cause of morbidity and mortality in children 
worldwide, where 98% of deaths occur in developing 
countries, including Indonesia [2], [3]. Results of the 
2013 Indonesian Basic Health Research stated in 
Riau Province, diarrhea was the second most common 
cause of toddlers’ mortality, accounting for 17.2% of all 
toddler deaths [4].
Glutamine is a non-essential amino acid 
with an abundant amount in the human body. In the 
gastrointestinal tract, glutamine is known as the main 
fuel of the intestinal mucosa that triggers enterocyte 
growth, increases intestinal barrier function, and 
increases blood circulation to the intestine, plays an 
important role in the synthesis of nucleic and amino acids 
in the intestinal barrier, maintains integrity of the tight 
junction, and acts as an immunomodulator. Glutamine 
is produced by the body in sufficient quantities, but its 
use tends to increase during illness including diarrhea, 
which causes glutamine depletion. This condition will 
interfere with the functions of glutamine and aggravate 
an illness. Diarrhea will be followed by damage to the 
intestine, and glutamine deficiency will inhibit its repair. 
Therefore, the supplementation of exogenous glutamine 
is needed to help the regeneration of damaged intestinal 
mucosa [5].
The benefits of glutamine as an adjuvant in 
managing diarrhea have been obtained based on several 
studies. A study by Radha and Samak and Vicario et al. 
and Carneiro-Filho et al. showed that glutamine has 
protective properties for mucosal barriers because of its 
effects on maintaining the integrity of intestinal epithelial 
tight junction cells [6], [7], [8]. In addition, glutamine 
could also facilitate enteral absorption of nutrients 
and electrolytes in diarrhea and reduce the severity of 
diarrhea by increasing water and salt uptake [9].
Based on a previous study, glutamine 
can improve intestinal growth, promote enterocyte 
proliferation and survival, and regulate the intestinal 
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barrier function during injury, infection, stress, and 
catabolic conditions. This effect occurs because 
glutamine can maintain intracellular redox status and 
regulate gene expression associated with various 
signaling pathways [10]. Research from Roedi Irawan 
also supported that glutamine could repair ileal microvilli 
in malnourished rats. In addition, an increase in intestinal 
enzyme activity, namely, sucrase, maltase, lactase, 
spectrin, as well as clathrin was found. This growing 
evidence supports the idea that glutamine is beneficial 
for intestinal repair [11]. Furthermore, a study by Huang 
showed the beneficial of glutamine on improvement 
of Rattus norvegicus strain Wistar’s intestinal that is 
experiencing chronic diarrhea [12]. However, different 
results are shown from study by Kamucakhi about 
the benefits of glutamine supplementation in children 
who experience chronic diarrhea, in which glutamine 
supplementation showed no useful results [13]. This 
study aimed to determine the relationship between 
glutamine supplementation and fecal calprotectin, 
sIgA, TNF-α in the fecal of rats with acute and chronic 
diarrhea induced by EPEC.
Materials and Methods
This study was conducted in an experimental 
laboratory study using a randomized post-test only 
control group design.
Experimental samples
The sample of this study consisted of male rats 
(Wistar strain of Rattus norvegicus) aged 10–16 weeks, 
with a body weight of 160–250 g. The samples were 
divided into five groups with six rats/group: Negative 
control group (K), acute diarrhea group (A), acute 
diarrhea group supplemented with glutamine (Kyowa 
Hakko Bio Co., Made in Japan) at a dose of 
810 mg/200 g rat (B), chronic diarrhea group (C), and 
chronic diarrhea group supplemented with glutamine at 
a dose of 810 mg/200g rat (D). The dose of glutamine 
given to the rats was based on the human-to-animal 
dose conversion factors. The dose in humans is 
45 mg/day at a body weight of 70 kg, converted into 
0.018 mg/day for rat.
Experimental design
Rats are placed in plastic cages with a lid 
made of ram wire and are given a filter paper mat 
to observe rats faces. The pad is replaced 3 times a 
week. The cage is placed in a well-ventilated room 
with good air circulation. The environment of cage is 
made so that it is not humid, the temperature of the 
cage is maintained according to room temperature 
(20–26°C), and the exchange of dark and light every 
12 h. Each rat is placed in its own cage. All rats 
are giving food and drink is given ad libitum and 
monitored its health every day. Acute diarrhea was 
induced in Groups A and B using EPEC (2 ml with 
a population of 108 CFU/ml). Chronic diarrhea was 
induced in Groups C and D using EPEC (2 ml with a 
population of 108 CFU/ml, given doses of repetition 
every 3 days). Diarrheic rats in Groups A and C were 
given the standard feeding, while those in Groups B 
and D were given glutamine for 14 days at a dose of 
810 mg/200 g/day as soon after diagnosed by acute 
and chronic diarrhea. On the 15th day after standard 
feeding and glutamine supplementation, glutamine is 
given at a dose of 810 mg/200 g which is dissolved 
with aqua as much as 4 ml orally using sonde every 
day for 14 days. The rats’ feces were taken from the 
ileum, weighing 15 mg for 100 μl PBS.
Fecal calprotectin analysis
Fecal calprotectin levels were analyzed 
according to the instruction manual on the rat 
calprotectin ELISA Kit. Feces/stool taken from the 
caecum is centrifuged for 20 min at a speed of 5000 rpm. 
Supernatants are carefully taken, the sample can be 
stored at −20°C or −80°C. Before the examination is 
carried out, the sample is placed at room temperature 
(18°C–25°C) for 30 min. Next prepare the standard 
well, sample well, and blank well. Standard solutions, 
samples, and blanks of 100 μl were put into each well on 
the plate, and then the plate was closed and incubated at 
room temperature for 1 h. The solution is well aspirated, 
and then the plate is washed up to three times with wash 
solution. Then, 50 μl of chromogen Reagent A solution 
is added to each well and re-incubated for 15 min at 
room temperature, keeping the plate closed in the 
dark. Next 50 ml of chromogen Reagent B solution was 
added and incubated for 15 min at room temperature. 
The plates are washed 5 times, then 90 μl substrate 
solution (Tetramethylbenzidine) is added to each well 
and incubated for 10 min at room temperature in a dark 
room (the liquid will turn blue). After 10 min, 50 μl of 
stop solution (sulfuric acid) is added to each well (the 
liquid will turn yellow), then read on a microplate reader 
with a wavelength of 450 nm.
Fecal TNF-α level analysis
TNF-α levels were analyzed according to the 
instruction manual on the TNF-α ELISA Kit Rat. Stool 
taken from the caecum is centrifuged for 20 min at a 
speed of 5000 rpm. Supernatants are carefully taken, 
the sample can be stored at −20°C or −80°C. Before 
the examination is carried out, the sample is placed 
at room temperature (18°C–25°C) for 30 min. Next 
prepare the standard well, sample well, and blank well. 
Standard solutions, samples, and blanks of 100 μl were 
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put into each well on the plate, and then the plate was 
closed and incubated at room temperature for 1 h. The 
solution is well aspirated, and then the plate is washed 
up to 3 times with wash solution. Then, 50 μl of the 
detection Reagent A solution is added to each well and 
re-incubated for 15 min at room temperature, keeping 
the plate closed in the dark. Next 50 ml of detection 
Reagent B solution was added and incubated for 15 min 
at room temperature. The plates are washed 5 times, 
then 90 μl substrate solution (Tetramethylbenzidine) is 
added to each well and incubated for 10 min at room 
temperature in a dark room (the liquid will turn blue). 
After 10 min, 50 μl of stop solution (sulfuric acid) is 
added to each well (the liquid will turn yellow), then 
read on a microplate reader with a wavelength of 
450 nm.
Statistical analysis
Statistical analysis was performed with SPSS 
version 19. The sample was tested to determine 
different effect of glutamine on fecal calprotectin and 
TNF-α in acute and chronic diarrhea rats, one-way 
ANOVA test was used, if it was obtained p < 0.05 
followed by post hoc Bonferroni test.
Research ethics requirements
This study has obtained ethical approval 
from the Faculty of Medicine, University of Riau (15.3/
UN19.5.1.1.8/UEPKK/2018).
Results
Fecal calprotectin and TNF-α were assessed 
on day 15 after glutamine supplementation, in the 
K group (negative control), A group (rats with acute 
diarrhea not given glutamine), B group (rats with acute 
diarrhea given glutamine supplementation), C group 
(rats with chronic diarrhea not given glutamine), and 
D group (rats with chronic diarrhea given glutamine 
supplementation). Furthermore, an analytical test using 
the one-way ANOVA method is presented in Table 1.
Tabel 1: Effect of glutamine administration on the mean levels 
of fecal calprotectin in rats on acute diarrhea group
Group n Mean (SD) µg/ml p
K 6 62.379 (8.45) 0.107
A 6 74.723 (11.76)
B 6 72.130 (9.11)
K: Control, A: Acute diarrhea, B: Acute diarrhea + glutamine
Table 1 shows that there were differences in 
the mean levels of fecal calprotectin between rats in 
Groups K, A, and B. The rates of fecal calprotectin 
increased in rats in Group A, namely, acute diarrhea rats 
(74.723 µg/ml) compared with rats in Group B, namely, 
acute diarrhea rats with glutamine administration 
(72.130 µg/ml), and are higher than the average level 
of fecal calprotectin in Group K rats, namely, the 
control group rats (62.379 µg/ml). However, statistically 
obtained p > 0.05, so it can be concluded that there 
is no significant difference from the average fecal 
calprotectin levels in acute diarrhea group rats.
Table 2 shows that there were no significant 
differences in the fecal calprotectin levels of Groups K 
and A rats with p > 0.05. There were no significant 
differences in the fecal calprotectin levels in Groups K 
and B rats as well as in rats Group A and B with 
p > 0.05. It can be concluded that the difference in fecal 
calprotectin levels in each acute diarrhea group was not 
statistically significant.
Table 2: Effect of glutamine administration on fecal calprotectin 
levels in each rats on acute diarrhea group
Group K A B
K - 0.141 0.324
A 0.141 - 1.000
B 0.324 1.000 -
K: Control, A: Acute diarrhea, B: Acute diarrhea + glutamine
Table 3 shows that there were differences in 
the mean TNF-α levels between Group K, A, and B 
rats. There was an increase in TNF-α mean in Group A 
(223.878 µg/ml) and Group B (229.382 µg/ml) compared 
to Group K rats (161.358 µg/ml). Group A is lower than 
Group B. Statistically obtained p < 0.05 so that it can 
be concluded that there is a significant difference in the 
mean TNF-α levels in rats in the acute diarrhea group. 
Furthermore, to find out the significant differences in 
each group, an analysis using post hoc Bonferroni is 
presented in Table 4.
Table 3: Effect of glutamine administration on the mean levels 
of TNF-α in the rats on acute diarrhea group
Group n Mean (SD) µg/ml p
K 6 161.358 (26.68) 0.016
A 6 223.878 (52.29)
B 6 229.382 (34.69)
K: Control, A: Acute diarrhea, B: Acute diarrhea + glutamine
Table 4 shows that there were significant 
differences in the TNF-α levels of rats in Groups K and 
A and in rats in Groups K and B with p < 0.05. There 
was no significant difference in TNF-α levels in rats 
Group A and B with p > 0.05. It can be concluded that 
the differences in the TNF-α levels of rats in Groups K 
and A and Groups K and B are statistically significant.
Table 4: Effect of glutamine administration on TNF-α levels in 
each rats on acute diarrhea group
Group  K  A  B
K - 0.045* 0.027*
A 0.045* - 1.000
B 0.027* 1.000 -
K: Control, A: Acute diarrhea, B: Acute diarrhea + glutamine
Discussion
In this study was shown an increase in levels 
of fecal calprotectin in rats in the acute diarrhea group 
and acute diarrhea with glutamine. This shows the 
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occurrence of inflammation in the intestinal cells of 
experimental rats induced by EPEC. Fecal calprotectin 
can be used as a biomarker for inflammation of intestinal 
cells and increases significantly in diarrhea due to 
bacterial infection. High fecal calprotectin levels also 
correlate with the clinical severity of infectious diarrhea 
in children, the more severe the clinical, and the higher 
the fecal calprotectin; therefore, fecal calprotectin can 
be used as a marker for inflammation in the intestine 
and as an evaluation of therapeutic management [14].
Although in this study the levels of fecal 
calprotectin in acute diarrhea rats given glutamine were 
lower than those in diarrhea rats that were not given 
glutamine, which suggests that glutamine might have 
the effect of reducing inflammation, statistically this was 
not significant. The previous studies conducted by Vidal-
Casariegot (2013), also found no significant difference 
in calprotectin levels after glutamine administration 
to prevent enteritis in patients on radiotherapy [15], 
although the pathophysiology of the study was different.
Calprotectin is a protein complex found in 
mammals. In the presence of calcium, calprotectin 
can inhibit the transition from manganese and zinc 
through the mechanism of chelation, this mechanism 
(inhibiting the transition from manganese and zinc) is 
an attempt to kill bacteria in innate immunity; therefore, 
calprotectin is known to have an antimicrobial function. 
Calprotectin is mostly (up to 60%) present in dissolved 
proteins in cytosols and neutrophils, although it can 
be found in monocytes, macrophages, and squamous 
epithelial cells [16]. Secretion from calprotectin will 
increase in the inflammatory response. Calprotectin 
can be found in the intestinal lumen through several 
mechanisms including increased effects of leukocytes, 
active secretion, cell disruption, and cell death. As 
a result, there is an increase in fecal calprotectin 
levels, which can be detected in feces. An increase 
in fecal calprotectin indicates there is migration of 
neutrophils into the intestinal mucosa, due to intestinal 
inflammation [17].
The results of this study indicate that statistically 
there are significant differences in the TNF-a group of 
acute diarrhea. These results differ from the previous 
studies conducted by Ameho in 1997, which showed 
glutamine can suppress TNF-α in colitis-induced rats, 
where the average TNF-α concentration in the group 
given glutamine was 4% and 2% lower than in the 
control group, the concentration this low level indicates 
the role of glutamine in inhibiting the synthesis, release, 
and action of pro-inflammatory cytokines which have an 
impact on the clinical improvement of the disease [18].
This average difference might occur because 
there are different glutamine doses, in which in this study 
a dose of 810 mg/200 g of rats (4.05 g/kg) was used, 
whereas the study from Ameho used a higher dose of 
40 g/kg/day and a dose of 20 g/kg/day. Research from 
Ameho also shows better results from groups of rats 
with higher doses than lower ones [18]. Research from 
Yalcin in 2004, with low doses (0.3 g/kg) also found no 
benefit of glutamine immunologically [19].
In this study also found levels of TNF-α in 
Groups A and B there were no statistically significant 
differences. This was also found in Ameho, where in the 
control group and the treatment group, although there 
were clinical differences, the difference in TNF-α was not 
statistically significant. Research from Ameho has not yet 
found an explanation for this, however, it is well known 
that the serum concentration of TNF-α is not always 
consistent with the severity of the disease being low [18].
The results of this study are consistent with 
the previous studies conducted by Ameho in 1997, 
which showed glutamine can suppress TNF-α in colitis-
induced rats, where the average TNF-α concentration 
in the group given glutamine was 4% and 2% lower 
than the control group, this low concentration indicates 
the role of glutamine in inhibiting the synthesis, release, 
and action of pro-inflammatory cytokines, which have an 
impact on the clinical improvement of the disease [18].
In the early stages of infection, activation of 
the inflammatory reaction occurs. NF-κB, which is a 
multiprotein complex, composed of p50, p52, p65, 
RelB, and c-Rel. In good health, NF-κB is stored in 
the cytoplasm and remains inactive with the help of 
an inhibitor of κB (I-κB). In response to extracellular 
stimulus, I-κB kinase performs phosphorylation of the 
I-κB protein, resulting in I-κB degradation which causes 
the release and activation of NF-κB. This active NF-κB 
complex then moves into the nucleus and induces 
expression of the NF-κB-binding element gene, such as 
IL-6 and TNF-α. In this inflammatory state, production 
of IL-6 and TNF-α increases rapidly, which stimulates 
immune responses, such as antigen-presenting cells 
and T-cells [10].
Glutamine predicted to inhibit these pathways 
with multimodal. There are several mechanisms 
by which glutamine can suppress TNF-α, including 
inhibition of IκBα-ubiquitination, inhibition of activation 
of NF-kB, which has an impact on suppressing the 
production of IL-6, IL-8, and TNF-α, and reducing 
regulation of signal transducers and activators of 
transcription (transcription). The previous studies 
have shown that glutamine supplementation can be 
a promising candidate for treating this inflammatory 
disease [10]. Supplementation of glutamine for 14 days 
can reduce fecal calprotectin levels in chronic diarrhea 
and reduce TNF-α level in rats with acute diarrhea.
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